2014
DOI: 10.1016/j.surg.2013.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
35
0
9

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 56 publications
(47 citation statements)
references
References 39 publications
3
35
0
9
Order By: Relevance
“…However, the procedure had an important beneficial effect, which can be explained by the reduction of the toxic effects of PTH, causing multiple organ damage and exuberant symptomatology 28 . These improvements validate the indication of parathyroidectomy as early as possible in CKD 29,30 . The present study has some limitations that include the low number of participants, due to the financial difficulties of a public hospital, and the lack of information about the body weight gain after PTx.…”
Section: Discussionsupporting
confidence: 63%
“…However, the procedure had an important beneficial effect, which can be explained by the reduction of the toxic effects of PTH, causing multiple organ damage and exuberant symptomatology 28 . These improvements validate the indication of parathyroidectomy as early as possible in CKD 29,30 . The present study has some limitations that include the low number of participants, due to the financial difficulties of a public hospital, and the lack of information about the body weight gain after PTx.…”
Section: Discussionsupporting
confidence: 63%
“…Differences between the two groups on improving muscle weakness and alleviating pruritus were not statistically significant. Cheng et al [23] study applied a 13 symptoms questionnaire in patients with sHPT. They demonstrated that PTX is associated with marked improvement in all symptoms and in quality of life.…”
Section: Discussionmentioning
confidence: 99%
“…The population of patients with ESRD is very heterogeneous with respect to underlying etiology of kidney failure, age and additional co-morbidities, and this may influence decision making regarding referral and/or consideration of parathyroidectomy. (25, 26) For this reason, sicker patients with a greater degree of co-morbid disease may have not been considered for referral or declined surgical intervention, resulting in an inclusion bias. We cannot tell how many patients with above target KDIGO for calcium, phosphate and/or PTH were not referred for surgical consideration.…”
Section: Discussionmentioning
confidence: 99%